IMAGE SOURCE: GETTY IMAGES.
Healthcare stocks in general have fared all right over the past 12 months, but there have also been quite a few losers among them. Big pharma stocks in particular have experienced mixed results, and three major drugmakers have performed especially poorly: Novartis (NYSE: NVS), Novo-Nordisk (NYSE: NVO), and Sanofi (NYSE: SNY).